SHIVALIKShivalik Rasayan Limited
Metals · Agricultural Inputs · NSE · as of 2026-10-28 (delayed ~30 min in market hours)
Shivalik Rasayan Limited produces and sells chemicals for the protection of plants in India. The company offers Dimethoate technical used in the preparation of formulations for use in the control of various insects and mites; and Malathion technical, an organophosphorus based contact insecticide used in the agricultural production of various food/feed crops. It also manufactures organophosphorus-based insecticides and chemicals. In addition, the company develops and manufactures active pharmaceutical ingredients (APIs) in oncology, ARVs, cardiovascular, metabolic disorders, and immunology; and manufactures oncology and non-oncology products. It serves pesticides formulators and finished dosages formulators of pharmaceutical products. The company was incorporated in 1979 and is based in New Delhi, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on SHIVALIK — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Risk gate: safety score is only 28/100 — volatility, drawdown or liquidity is too poor for a buy call, whatever the chart says
- • Revenue growth: 7.9% YoY
- • ROE: 2.9%
- • RSI: 39
- • MACD: bearish
Bull case
- • Profit growth: 111.8% YoY
- • Debt/Equity: 0.19
- • Promoter holding: 58.1%
- • Price vs SMA200: above
Bear case
- • Revenue growth: 7.9% YoY
- • ROE: 2.9%
- • RSI: 39
- • MACD: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Revenue growth: 7.9% YoY
- • ROE: 2.9%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹20.01). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.